Generate Biomedicines has completed its IPO, raising an impressive $400 million that makes it the largest listing for a biotech on the Nasdaq so far this year. Incubated by investment group Flagship ...
CNCF launches Dapr Agents v1.0 at KubeCon EU, prioritizing crash recovery and durability over intelligence. Zeiss validates ...